HeyJaredAlex Young
- Indexed articles, last 90 days
- 11
- Latest publication
- Aug 28, 2026
- Outlet visibility, for Healio
- Top 500K sites
- Earliest in this view
- Jul 21, 2026
Latest articles
Newer IOL formulas more accurate for hitting myopic target (opens the original)
Read excerpt
Newer IOL power calculations have good accuracy in eyes with intentional myopic targets, according to a study published in Journal of Refractive Surgery. Francesco Biagini, MD, of San Martino Hospital, Genoa, Italy, and colleagues wrote that IOL calculations have improved to the point where patients expect better results. âHowever, there are still patients who prefer to perform near activity without glasses and thus require a myopic target,â the authors wrote. âOnly a few studies have inve
ICL implantation may improve dynamic visual acuity (opens the original)
Read excerpt
Patients with myopia had better dynamic visual acuity after receiving an ICL, according to a study published in Journal of Refractive Surgery. Tianze Huang, MD, of Chinese Academy of Medical Sciences and Peking Union Medical College Hospital, Beijing, and colleagues wrote that because dynamic visual acuity (DVA) indicates how well someone can identify the details of a moving object, it can be an important tool for clinicians to assess a patientâs full visual function. âCurrent evaluation of
Dilation may alter IOL power calculations (opens the original)
Read excerpt
Pupil dilation could skew IOL power calculations by increasing anterior chamber depth and reducing lens thickness, according to a study published in Journal of Refractive Surgery. âBecause biometry and IOL power calculations are commonly performed on the same day once a decision for surgery has been made, biometry is usually performed while the patientâs pupils are still dilated,â David Z. Chen, MBBS, FRCOphth, of National University Hospital in Singapore, and colleagues wrote. âCurrentl
Keep planning simple for CAIRS procedures (opens the original)
Read excerpt
KIAWAH ISLAND, S.C. â Surgeons who perform corneal allogenic intrastromal ring segment procedures should keep planning simple, according to a speaker at Kiawah Eye & Retina. In a presentation, Neel R. Desai, MD, shared pearls and what he wished he knew before he started using corneal allogenic intrastromal ring segments (CAIRS) in patients with keratoconus, specifically when placing the ring segments using manual dissection. âWhen you conceptually think about dissecting or cross planes with
Tarsus to acquire Alkeus, iRenix (opens the original)
Read excerpt
Tarsus Pharmaceuticals is entering the retina space with deals to acquire Alkeus Pharmaceuticals and iRenix Medical, according to press releases. The acquisitions are focused on two therapies: gildeuretinol (ALK-001, Alkeus Pharmaceuticals) and IRX-101 (iRenix Medical). Gildeuretinol is an investigational once-daily oral therapy for the treatment of Stargardt disease designed to reduce damage to the retina caused by the accumulation of toxic dimers, while IRX-101 is an investigational ocular ant
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 500K sites
For Healio, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.